ARPA-H directs $41 million to Alzheimer's prevention clinical trials
The Advanced Research Projects Agency for Health is funding clinical trials of supplements and approved drugs intended to prevent dementia in people at risk, Science reported.
The Advanced Research Projects Agency for Health is providing $41 million for clinical trials examining whether supplements and already approved drugs can help prevent dementia in people at risk of Alzheimer's disease.
Science reported that the funding comes as blood tests intended to identify Alzheimer's-related risk move closer to broader use.